Gelteq Limited (GELS)

Gelteq Limited is an Australian company that develops gel-based delivery formats for nutraceuticals, pharmaceuticals and pet health products. Its technology turns ingredients that are usually taken as pills, capsules or powders into edible gels, intended to make them easier to swallow and more palatable.

The company pursues its business through product development, white-label manufacturing arrangements and licensing of its gel formulations to partner brands in areas such as sports nutrition, dietary supplements and animal health. Gelteq is headquartered in Melbourne, Australia, and its ordinary shares trade on the Nasdaq following its 2024 initial public offering.